Drug or treatment
Ziltivekimab clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Ziltivekimab that are recruiting, at sites in 6 countries (most in Switzerland (2), Austria (1), Denmark (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Ziltivekimab to reduce plaque in heart arteries after a heart attack
This trial will test whether ziltivekimab can reduce plaque in the heart's blood vessels in adults who recently had a heart attack.
-
Ziltivekimab to reduce coronary plaque after a heart attack
This study will test whether the anti-inflammatory drug ziltivekimab can reduce plaque buildup and improve plaque composition in people who recently had a heart attack and were treated with PCI.
Quick answers
How many clinical trials of Ziltivekimab are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Switzerland (2 trials), Austria (1 trial), Denmark (1 trial), Italy (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.